Clinical trial

Effects of Cervical Lidocaine Spray on Pain Relief During Manual Vacuum Aspiration : A Randomized Controlled Trial

Name
2566/081 I
Description
This randomized control trial aim to evaluate the effectiveness of local lidocaine spray application to the cervix on the reducing of pain score during the manual vacuum aspiration
Trial arms
Trial start
2023-12-14
Estimated PCD
2024-05-30
Trial end
2024-07-30
Status
Active (not recruiting)
Treatment
10 % lidocaine spray without adrenaline
Pateint with indication for manual vacuum aspiration aged between 20-60 years will received a standard injection of pethidine along with 1% lidocaine spray without adrenaline on cervical os to compare pain scores with placebo. Along with measuring side effects immediately and 30 minutes after receiving 1% lidocaine without adrenaline.
Arms:
10% lidocaine spray without adrenaline
Other names:
10% Xylocaine spray
Placebo
4 puffs of normal saline apply on cervical os before manual vacuum aspiration
Arms:
Placebo
Size
216
Primary endpoint
pain score during manual vauum aspiration
during surgery
pain score after manual vauum aspiration
at 30 minutes postoperative
Eligibility criteria
Inclusion Criteria: * female ageed 20 years to 60 years who have an indication for manual vacuum adpiration under intraveneous analgesia Exclusion Criteria: * patient with allergic to lidocaine or history of allergic to lidocaine * patient with reproductive and urinary infection * patient with abnormal vital sign * patient with abnormal kidney and liver function test
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['NA'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'DOUBLE', 'whoMasked': ['PARTICIPANT', 'CARE_PROVIDER']}}, 'enrollmentInfo': {'count': 216, 'type': 'ACTUAL'}}
Updated at
2024-04-03

1 organization

1 product

4 indications

Product
Lidocaine
Indication
Pain
Indication
Procedural
Indication
Lidocaine